2026 International Congress » MSA, PSP, CBS: Neuroimaging

18F-FD4 PET Reveals α-Synuclein Deposition and Clinical Correlations in Multiple System Atrophy

J. Wang (Shanghai, China)

Associations Between FDG-PET Regional Metabolism and Clinical Severity in Progressive Supranuclear Palsy

M. Oliveira, V. Maciel, G. Martins, C. Carneiro, C. Buchpiguel, A. Coutinho, J. Parmera, E. Barbosa (São Paulo, Brazil)

Beyond Diagnosis: Putaminal ADC Hyperintensity and Infratentorial Signs Reflect Motor Severity in MSA

Y. Zhao, K. Li, Y. Zheng, M. Luan, H. Tang, C. He, J. Liu, F. Li, L. Wei, J. Chen, W. Sun, J. Deng, Z. Wang, Y. Zhu, Y. Sun (Beijing, China)

Can Parkinson’s Disease and Progressive Supranuclear Palsy be Distinguished Using Surgical Planning Image Analysis Software?

K. Matsuura, A. Nishigaki, S. Horie, K. Sakae, T. Utsunomiya, K. Miyashita, K. Tabei, A. Shindo (Tsu, Mie, Japan)

Central Autonomic Network Alterations in MSA: From Subcortical Degeneration to Prefrontal Reorganization

Y. Wang, A. He, W. Mao, P. Chen (Beijing, China)

Cholinergic Systems Changes Associated with Freezing of Gait in Progressive Supranuclear Palsy

P. Kanel, G. Carli, S. Roytman, J. Barr, R. Vangel, A. van Hout, C. Spears, P. Scott, R. Albin, N. Bohnen (Ann. Arbor, USA)

Choroid Plexus Morphology and Enhancement as Imaging Markers for Early Differentiation of Multiple System Atrophy and Parkinson’s Disease

S. Jo, D. Ambaye, M. Choi, G. Lee, S. Chung, E. Lee, H. Cho (Seoul, Republic of Korea)

Clinical Significance of Imaging Markers for Cerebellar Ataxia and Parkinsonism in Multiple System Atrophy

Y. Nakano, A. Sugiyama, Y. Nakagawa, M. Tamura, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, K. Osawa, T. Yamamoto, Y. Yamanaka, M. Mori, S. Hirano (Chiba, Japan)

Comparison of Regional Perfusion Patterns in Clinical Subtypes of PSP and CBD: Dual Phase [¹⁸F]FP CIT PET Study

C. Lee, S. Kim, J. Ko, D. Doudet (Seongnam, Republic of Korea)

Computer-Assisted Morphometric Analysis of Midbrain and Pons for Differential Diagnosis of Parkinsonian Disorders

P-W. Ko (Daegu, Republic of Korea)

Correlation Analysis of Cortical Activation and Aspiration Risk During Swallowing in Patients with Multiple System Atrophy

YF. Xia, B. Xiong, P. Wang, N. Chen, W. Luo (Hangzhou, China)

Cortical Mean Diffusivity as a Measure of Microstructural Neurodegeneration in Multiple System Atrophy

J. Pardo, V. Montal, C. Martín-Barceló, I. Roura, C. García-Vicente, C. Falcon, A. Campabadal, R. Sala-Llonch, N. Bargalló, J. Fortea, C. Painous, A. Pérez, A. Cámara, Y. Compta, C. Junqué, B. Segura, MJ. Martí (Barcelona, Spain)

Coupling of Cholinergic and Dopaminergic Terminal Loss in Progressive Supranuclear Palsy: A Multimodal [18F]FEOBV and [11C]PE2I Study

P. Kanel, G. Carli, S. Roytman, J. Barr, R. Vangel, A. van Hout, C. Spears, P. Scott, R. Albin, N. Bohnen (Ann. Arbor, USA)

Diagnostic Utility of [18F]FDG-PET in the Differential Diagnosis of Parkinsonian Syndromes: A Retrospective Study in an Indian Tertiary Care Cohort

A. Mani, J. Hephzibah (Ranipet, India)

Diagnostic Utility of Routine 1.5T Brainstem Planimetry in Parkinsonism: Evidence from a Vietnamese Cohort

D. Nguyen, T. Tran (St Lucia, Australia)

Differential Cholinergic White Matter Microstructural Alterations in Multiple System Atrophy and Parkinson’s Disease

SM. Rong, R. Yang, ZH. Li, XL. Cui, CT. He, MF. Cai, YH. Zhang (Guangzhou, Guangdong Province, China)

Distinct FDG PET Metabolic Signatures and Dopaminergic Loss Across Multiple System Atrophy Subtypes

T. Carther-Krone, J. Perron, CS. Lee, JH. Ko (Winnipeg, Canada)

Distinct FDG-PET metabolic patterns and connectivity alterations in dopamine transporter-deficient versus -preserved MSA-C

Y. Zhao, H. Lin, X. Li, J. Ge, F. Liu (Shanghai, China)

Emerging Roles for Imaging Techniques in Differentiating Underlying Pathologies in Corticobasal Syndrome

P. Bhaya, D. Petrosyan, N. Nguyen, L. Saadatpour, E. Vaou, S. Horn, P. Coss (San Antonio, USA)

Evaluating Magnetic Resonance Parkinsonism Index (MRPI) and MRPI 2.0 as Radiographic Metrics to Differentiate Progressive Supranuclear Palsy (PSP) from Normal Pressure Hydrocephalus (NPH)

R. Mani, M. Murphy, C. Zheng, C. Pol, M. Egnor, G. Schwartz (Stony Brook, USA)

Local Glymphatic Dysfunction in Multiple System Atrophy: Insights from Multimodal MRI

J. Pardo, C. Martín-Barceló, C. Roura, C. García-Vicente, C. Falcon, A. Campabadal, R. Sala-Llonch, N. Bargalló, C. Painous, A. Pérez, A. Cámara, M. Buongiorno, Y. Compta, C. Junqué, B. Segura, MJ. Martí (Barcelona, Spain)

Mapping Intrinsic Brain Network Connectivity Using Resting-State Functional MRI In Spinocerebellar Ataxia 12 In Comparison with Healthy Controls

P. Pankaj, M. Kumar, S. Kumaran, A. Srivastava, A. Garg, R. Agrawal, A. Nehra, R. Rajan (New Delhi, India)

Microstructural cortical alterations are related to cognitive and disease severity in progressive supranuclear palsy

C. Garcia Vicente, J. Pardo, C. Martín-Barceló, I. Roura, C. Falcon, R. Sala-Llonch, A. Campabadal, N. Bargalló, O. Brengaret, C. Brenlla, C. Painous, A. Cámara, M. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

Multi-Sequence MRI-Based Machine Learning Model for Differentiating Parkinson Disease (PD) from Multiple System Atrophy (MSA)

Y. Wang, N. He, M. Haacke, F. Yan, G. Yang, P. Lewitt (Shanghai, China)

Multicenter Evaluation of Automated Structural MRI-based Diagnosis for Multiple System Atrophy

K. Kawabata, H. Takeshige-Amano, T. Hatano, T. Baba, A. Takeda, S. Kuwabara, A. Ogura, M. Katsuno, R. Hanajima, M. Matsushima, I. Yabe, M. Hatakeyama, O. Onodera, H. Watanabe (Tokyo, Japan)

Novel Structural MRI-Based Progression Subtypes and Prognostic Study in Multiple System Atrophy

Y. Kang, J. Li, W. Md (Hangzhou, China)

Prospective Comparison of Volumetric and Diffusion MRI Biomarkers for Multiple System Atrophy

F. Marchand, R. Viard, D. Devos, L. Defebvre, T. Ollivier, G. Kuchcinski, C. Moreau (Lille, France)

QSM-Based Substantia Nigra Volumetry Improves Differentiation of Progressive Supranuclear Palsy from Parkinson’s Disease and Multiple System Atrophy

S. Chung, S. Jo, H. Candan, M. Choi, G. Lee, E. Lee, H. Cho (Seoul, Republic of Korea)

Quanti-tau-PET Study of PI‑2620 Tau-PET Quantification in Progressive Supranuclear Palsy

Y. Compta, A. Niñerola-Baizan, C. Painous, R. Tudela, A. Camara, M. Fernandez, I. Zaro, S. Rubi, P. Bibiloni, A. Perissinotti (Barcelona, Spain)

Regional Distribution and Concordance of Structural MRI and 18F-FDG PET/MRI Findings in Parkinson-Plus Syndromes

A. Gunduz, C. Dönmez, F. Bayır, L. Uslu Beşli, O. şahin, H. Apaydın (Istanbul, Turkey)

Reversible encephalitic Parkinsonism due to bilateral substantia nigra lesion showing preserved nigrostriatal dopaminergic activity

B. Ku, M. Seo, J. Lee, H. Ku (Incheon, Republic of Korea)

Role of florzolotau (18F) positron emission tomography in the diagnosis and clinical management of progressive supranuclear palsy: a real-world study

KW. Chan, XY. Li, JY. Lu, C. Zuo, J. Wang, FT. Liu (Shanghai, China)

Systemic Inflammation and Cerebral Small Vessel Disease in Progressive Supranuclear Palsy

M. Tian, Y. Yin, D. Guo, P. Li, C. Song, Y. Liu (Jinan, China)

TMEM106B Amyloid Fibrils in the Choroid Plexus Mediate [18F]AV-1451 Retention: Cohort-Level Imaging and Cryo-EM Evidence

Y. Fan, WB. Zhao, QY. Zhao, JY. Lu, D. Li, J. Wang (Shanghai, China)

Volumetric Imaging Diagnostic Tool to Differentiate Progressive Supranuclear Palsy from Parkinson’s Disease using Artificial Intelligence

MS. Cho, JY. Youn, JW. Cho, HJ. Yoo, SJ. Oh, JH. Ahn, JW. Yu, MJ. Chung (Seoul, Republic of Korea)